Literature DB >> 2536517

Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.

R A DiGiacomo1, J M Kremer, D M Shah.   

Abstract

PURPOSE: The ingestion of omega-3 fatty acids could benefit patients with Raynaud's phenomenon because, among other effects, these fatty acids induce a favorable vascular response to ischemia. The aim of our study was to investigate, in a double-blind, placebo-controlled manner, the effects of fish-oil fatty-acid dietary therapy in patients with rheumatic disease. PATIENTS AND METHODS: Thirty-two patients with primary or secondary Raynaud's phenomenon were randomly assigned to olive-oil placebo or fish-oil groups. Patients ingested 12 fish-oil capsules daily containing a total of 3.96 g eicosapentaenoic acid and 2.64 g docosahexaenoic acid or 12 olive-oil capsules and were evaluated at baseline and after six, 12, and 17 weeks. All patients ingested olive oil between Weeks 12 to 17. Digital systolic blood pressures and blood flow were measured at room air and water baths of 40 degrees C, 25 degrees C, 15 degrees C, and 10 degrees C using strain gauge plethysmography. Onset of Raynaud's phenomenon was timed with a stop watch and defined as plethysmographic evidence of cessation of blood flow and blood pressure in the study finger.
RESULTS: In the fish-oil group, the median time interval before the onset of Raynaud's phenomenon increased from 31.3 +/- 1.3 minutes baseline to 46.5 +/- 2.1 minutes at six weeks (p = 0.04). Patients with primary Raynaud's phenomenon ingesting fish oil had the greatest increase in the time interval before the onset of the condition. Five of 11 patients (45.5 percent) with primary Raynaud's phenomenon ingesting fish oil in whom the phenomenon was induced at baseline could not be induced to develop Raynaud's at the six- or 12-week visit compared with one of nine patients (11 percent) with primary Raynaud's ingesting olive oil (p = 0.05). The mean digital systolic pressures were higher in the patients with primary Raynaud's phenomenon ingesting fish oil than in patients with primary Raynaud's ingesting olive oil in the 10 degrees C water bath (+32 mm Hg, p = 0.02).
CONCLUSION: We conclude that the ingestion of fish oil improves tolerance to cold exposure and delays the onset of vasospasm in patients with primary, but not secondary, Raynaud's phenomenon. These improvements are associated with significantly increased digital systolic blood pressures in cold temperatures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536517     DOI: 10.1016/0002-9343(89)90261-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

1.  Prevalence of Raynaud's phenomenon in a healthy Greek population.

Authors:  P V Voulgari; Y Alamanos; D Papazisi; K Christou; C Papanikolaou; A A Drosos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 2.  Raynaud's syndrome.

Authors:  E D Cooke; A N Nicolaides
Journal:  BMJ       Date:  1990-03-03

Review 3.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 4.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

5.  PubMedMiner: Mining and Visualizing MeSH-based Associations in PubMed.

Authors:  Yucan Zhang; Indra Neil Sarkar; Elizabeth S Chen
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

6.  Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.

Authors:  Justin Mower; Devika Subramanian; Trevor Cohen
Journal:  J Am Med Inform Assoc       Date:  2018-10-01       Impact factor: 4.497

Review 7.  The diagnosis and treatment of Raynaud's phenomenon: a practical approach.

Authors:  Janet E Pope
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Discovering discovery patterns with Predication-based Semantic Indexing.

Authors:  Trevor Cohen; Dominic Widdows; Roger W Schvaneveldt; Peter Davies; Thomas C Rindflesch
Journal:  J Biomed Inform       Date:  2012-07-26       Impact factor: 6.317

Review 9.  A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef.

Authors:  Cynthia A Daley; Amber Abbott; Patrick S Doyle; Glenn A Nader; Stephanie Larson
Journal:  Nutr J       Date:  2010-03-10       Impact factor: 3.271

10.  Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders.

Authors:  K Alonso; R Medenica
Journal:  J Natl Med Assoc       Date:  1995-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.